Monument Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-458
Closed -$238K 207
2024
Q3
$238K Sell
458
-66
-13% -$35.3K 0.07% 172
2024
Q2
$284K Buy
524
+11
+2% +$5.81K 0.08% 148
2024
Q1
$266K Sell
513
-129
-20% -$64.2K 0.08% 162
2023
Q4
$303K Buy
642
+122
+23% +$56.4K 0.1% 146
2023
Q3
$226K Sell
520
-359
-41% -$163K 0.08% 153
2023
Q2
$391K Buy
879
+13
+2% +$6K 0.12% 120
2023
Q1
$398K Sell
866
-117
-12% -$55.7K 0.13% 113
2022
Q4
$504K Buy
983
+12
+1% +$6.09K 0.17% 97
2022
Q3
$441K Buy
971
+465
+92% +$222K 0.17% 103
2022
Q2
$244K Buy
+506
New +$250K 0.09% 136
2019
Q2
Sell
-6,975
Closed -$2M 86
2019
Q1
$2M Sell
6,975
-206
-3% -$59.6K 1.14% 44
2018
Q4
$1.89M Buy
+7,181
New +$1.97M 1.18% 39

Other funds holding ELV

Monument Capital Management's ELV Position: Q4 2024 in Review

Monument Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 458 shares — an estimated $238K sold.

Monument Capital Management first reported a position in ELV in Q4 2018 and held it in 12 quarters. The position peaked at $2M in Q1 2019. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Monument Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Monument Capital Management sold 458 Elevance Health shares in Q4 2024, an estimated $238K.
  • Monument Capital Management first reported a position in Elevance Health in Q4 2018 and held it in 12 quarters.
  • Monument Capital Management's Elevance Health position peaked at $2M in Q1 2019.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Monument Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.